ES2177676T3 - Emulsion adecuada para administrar un esfingolipido y uso de la misma. - Google Patents

Emulsion adecuada para administrar un esfingolipido y uso de la misma.

Info

Publication number
ES2177676T3
ES2177676T3 ES95942970T ES95942970T ES2177676T3 ES 2177676 T3 ES2177676 T3 ES 2177676T3 ES 95942970 T ES95942970 T ES 95942970T ES 95942970 T ES95942970 T ES 95942970T ES 2177676 T3 ES2177676 T3 ES 2177676T3
Authority
ES
Spain
Prior art keywords
sphingolipide
administer
emulsion
adequate emulsion
adequate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95942970T
Other languages
English (en)
Inventor
Robert T Lyons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Eli Lilly and Co
Original Assignee
Pharmacia AB
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB, Eli Lilly and Co filed Critical Pharmacia AB
Application granted granted Critical
Publication of ES2177676T3 publication Critical patent/ES2177676T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PRESENTA UNA EMULSION ACIDICA QUE CONTIENE UN LIPOIDE DISPERSADO EN UNA FASE ACUOSA, UN ESFINGOLIPIDO CATIONICO Y UNA CANTIDAD ESTABILIZANTE DE SURFACTANTE NO IONICO Y COLESTEROL, ASI COMO UN METODO PARA LA ADMINISTRACION DE LA EMULSION.
ES95942970T 1994-12-07 1995-12-01 Emulsion adecuada para administrar un esfingolipido y uso de la misma. Expired - Lifetime ES2177676T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/351,635 US5635536A (en) 1994-12-07 1994-12-07 Emulsion suitable for administering a sphingolipid

Publications (1)

Publication Number Publication Date
ES2177676T3 true ES2177676T3 (es) 2002-12-16

Family

ID=23381694

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95942970T Expired - Lifetime ES2177676T3 (es) 1994-12-07 1995-12-01 Emulsion adecuada para administrar un esfingolipido y uso de la misma.

Country Status (10)

Country Link
US (2) US5635536A (es)
EP (1) EP0799035B1 (es)
JP (1) JPH10510267A (es)
AT (1) ATE216229T1 (es)
AU (1) AU4414096A (es)
DE (1) DE69526450T2 (es)
DK (1) DK0799035T3 (es)
ES (1) ES2177676T3 (es)
PT (1) PT799035E (es)
WO (1) WO1996017603A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720184B1 (en) 1991-08-05 2004-04-13 Emory University Method of altering sphingolipid metabolism and detecting fumonisin ingestion and contamination
US5965160A (en) * 1995-04-24 1999-10-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
US6982142B2 (en) 1997-12-01 2006-01-03 John Wayne Cancer Institute Methods for screening therapeutically effective agents
DE69943314D1 (de) * 1998-02-12 2011-05-12 Kapil N Bhalla Sphingolipid-derivate und verfahren zu deren verwendung
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
CA2335617C (en) * 1998-06-24 2009-12-15 Novirio Pharmaceuticals Limited Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
US6368831B1 (en) 1998-06-29 2002-04-09 Childrens Hospital Los Angeles Treatment of hyperproliferative disorders
AU4724599A (en) 1998-06-29 2000-01-17 Children's Hospital Of Los Angeles Treatment of hyperproliferative disorders
DE69912441T2 (de) 1998-08-19 2004-08-19 Skyepharma Canada Inc., Verdun Injizierbare wässerige propofoldispersionen
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations
AU2002354131A1 (en) * 2001-12-10 2003-06-23 Kao Corporation Ceramide emulsions
WO2004075834A2 (en) * 2003-02-21 2004-09-10 Childrens Hospital Los Angeles Research Institute Stabilized pharmaceutical compositions of safingol and methods of using the same
JP2006028109A (ja) * 2004-07-20 2006-02-02 Kao Corp 水中油型乳化組成物
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
WO2011044207A2 (en) * 2009-10-06 2011-04-14 L'oreal S.A. Compositions containing a high concentration of polar sphingolipid(s)
JP6960984B2 (ja) * 2019-12-26 2021-11-05 三菱電機株式会社 電子装置及びその絶縁部材

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792410B2 (de) * 1967-09-01 1980-03-13 Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm Arzneimittelzubereitung zur intravenösen Injektion
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤
IT1171432B (it) * 1981-08-03 1987-06-10 Fidia Farmaceutici Amidi organiche derivate da lipidi azotati utilizzabili come farmaci
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
US4937232A (en) * 1986-09-15 1990-06-26 Duke University Inhibition of protein kinase C by long-chain bases
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
US5198470A (en) * 1989-09-21 1993-03-30 L'oreal Lipid compounds derived from sphingosines, process for preparing these and their applications, in particular in cosmetics and in the pharmacy of skin conditions
FR2652002B1 (fr) * 1989-09-21 1991-11-29 Oreal Nouveaux composes lipidiques derives des sphingosines, leur procede de preparation et leurs applications, notamment en cosmetique et en dermopharmacie.
DE4015108A1 (de) * 1990-05-11 1991-11-14 Leopold Pharma Gmbh Stabile emulsion zur applikation pharmakologisch aktiver wirkstoffe
US5149794A (en) * 1990-11-01 1992-09-22 State Of Oregon Covalent lipid-drug conjugates for drug targeting
USH1168H (en) * 1991-08-21 1993-04-06 The United States Of America As Represented By The Secretary Of The Navy Inhibitors of protein kinase C activity as protectors against septic shock and reducers of ARDS

Also Published As

Publication number Publication date
JPH10510267A (ja) 1998-10-06
AU4414096A (en) 1996-06-26
WO1996017603A1 (en) 1996-06-13
DE69526450T2 (de) 2002-11-14
US5635536A (en) 1997-06-03
EP0799035A1 (en) 1997-10-08
EP0799035A4 (en) 1999-06-09
DE69526450D1 (de) 2002-05-23
ATE216229T1 (de) 2002-05-15
DK0799035T3 (da) 2002-07-22
EP0799035B1 (en) 2002-04-17
PT799035E (pt) 2002-09-30
US5677341A (en) 1997-10-14

Similar Documents

Publication Publication Date Title
ES2177676T3 (es) Emulsion adecuada para administrar un esfingolipido y uso de la misma.
NO20031249L (no) Emulsjonspreparater samt konsentrater derav
ATE232720T1 (de) Adjuvans für impfstoff
ES2123800T3 (es) Composicion para el cuidado de la piel que contiene vaselina emulsionada.
BR9403022A (pt) Composição cosmética ou dermatológica, processo para sua preparação e emulsão tipo óleo-em-água.
ES2081488T3 (es) Uso de fosfolipido en la fabricacion de un medicamento topico para modificar los niveles de colesterol serico.
AR009110A1 (es) Composicion cosmetica para mejorar la calidad de la piel humana
ATE172636T1 (de) Liposomales verabreichungssystem für biologisch aktive stoffe
BR9610089A (pt) Microemulsão não tóxica de óleo em água ou bicontínua processo para sua preparação e uso da mesma
NO308448B1 (no) Mikrosfærer samt fremstilling, preparater og anvendelse derav
DE69813498D1 (de) Verfahren zur freisetzung eines in einer multiplen emulsion enthaltenen aktivbestandteils
KR950701213A (ko) 대사 전환 가능한 오일을 함유하는 유증수(water-in-oil) 유체 왁진 에멀션(WATER-IN-OIL FLUID VACCINAL EMULSIONS CONTAINTING A METABOLIZABLE OIL)
BR9911849A (pt) Composição espumante para o cuidado dos cabelos e uso da mesma
ES2136315T3 (es) Uso de fluorocarbonos liquidos para facilitar la aportacion de medicamentos a los pulmones.
ES555722A0 (es) Un procedimiento para la preparacion de una formulacion que contiene derivados azolicos.
BR9712409A (pt) Formulação lìquida antimicrobiana aquosa para limpeza
TR199903271T2 (en) Tokoferol ile karl�la�t�r�lan soluma i�in prolipozom tozlar�.
BR0211008A (pt) Combinação de ingrediente ativo, uso de uma combinação de ingrediente ativo e método para a terapia farmacológia de uma substância que causa dependência ou que seja intoxicante
ATE145818T1 (de) Emulsion auf der basis von dihydroxyaceton und ihre verwendung in kosmetik
ES2174533T3 (es) Uso de una mezcla de un diol y un acido alfa-hidroxi para el tratamiento de enfermedades de la piel hiperqueratoticas.
CO4930309A1 (es) Emulsiones tipo aceite en agua que contienen cantidades suficientes de un agente emulsificante de agua en aceite para disminuir tiempo de absorcion por frotamiento
AR028752A1 (es) Composicion adecuada para la preparacion de una emulsion de aceite en agua
DE59301120D1 (de) Zubereitung zur topischen anwendung.
ES2059869T3 (es) Preparado farmaceutico que contiene piroxicam para uso topico.
ES2186343T3 (es) Formulacion topica de tipo emulsion de aceite en agua para proporcionar un efecto irritante reducido.